Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-Chemical Inhibitors & Agonists-PI3K/Akt/mTOR Pathway-mTOR-RMC-5552
RMC-5552

Chemical Structure : RMC-5552

CAS No.: 2382768-62-7

RMC-5552 (RMC5552)

Catalog No.: PC-49617Not For Human Use, Lab Use Only.

RMC-5552 (RMC5552) is a potent, selective bi-steric inhibitor of mTORC1 with cellular IC50 of 0.48 nM for p4EBP1 inhibition, 40-fold selectivity over mTORC2.

Packing Price Stock Quantity
25 mg Get quote
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    RMC-5552 (RMC5552) is a potent, selective bi-steric inhibitor of mTORC1 with cellular IC50 of 0.48 nM for p4EBP1 inhibition, 40-fold selectivity over mTORC2.
    RMC-5552 displays >53-fold selectivity over other lipid kinases.
    Treament of RMC-5552 resulted in a dose-dependent, prolonged, and profound inhibition of tumor p4EBP1 levels up to 48 h in Michigan Cancer Foundation-7 (MCF-7) breast cancer cell line, which bears an activating mutation in the p110α catalytic subunit of Phosphoinositide 3-kinase (PIK3CAE545K).
    RMC-5552 (10 mg/kg, ip, qw) reduced tumor volume in MCF-7 CDX models.

    Physicochemical Properties

    M.Wt 1778.16
    Formula C93H136N10O24
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20°C 12 Months; 4°C 6 Months
    In Solvent
    -80°C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    (1R,2R,4S)-2-Methoxy-4-((R)-2-((3S,5R,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-5,9,27-trihydroxy-10,21-ddimethoxy-6,8,12,14,20,26-hexamethyl-1,11,28,29-tetraoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1]oxa[4]azacyclohentriacontin-3-yl)propyl)cyclohexyl (27-(6-((4-Amino-3-(2-aminobenzo[d]oxazol-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-3,4-dihydroisoquinolin-2(1H)-yl)-27-oxo-3,6,9,12,15,18,21,24-octaoxahept

    References

    1. G Leslie Burnett, et al. J Med Chem. 2023 Jan 12;66(1):149-169.

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: